Skip to main content
Clinical Trials/NCT02800473
NCT02800473
Completed
Not Applicable

Evaluation of an Innovative Medical Device Made of a Bimodal Endoscopic Imager and of a Software for Panoramic Images Building of the Bladder Inner Wall (French National Research Agency, CyPaM2 Project, ANR-11-TECS-001) (CyPaM2)

Institut de Cancérologie de Lorraine1 site in 1 country10 target enrollmentJuly 4, 2016
ConditionsBladder Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bladder Cancer
Sponsor
Institut de Cancérologie de Lorraine
Enrollment
10
Locations
1
Primary Endpoint
Ergonomic comparaison of the two devices
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study evaluates the therapeutic value of: (i) simultaneous endoscopic visualization of the inner bladder using white light and blue light excitations and (ii) high resolution panoramic images of the bladder inner wall.

All participants will undergo fluorescence cystoscopy: the first half using first a reference medical device for fluorescence cystoscopy already on the market then using the innovative device specifically developped for the CyPaM2 project.

The other half will undergo fluorescence cystoscopy using first the innovative then the reference medical device.

Detailed Description

An innovative medical device was developped by the CyPaM2 project's partners.This device is made of a hardware and of a software part: (i) an imager (light source and sensors) for simultaneous and colocalized visualisation of the bladder using white light and blue light for fluorescence excitation and (ii) a mosaicing software for automatic building of high-resolution panoramic images of the bladder inner wall. The medical device's qualitative (human engineering, images qualitty) and quantitative (medical examination and panoramic images building durations) specifications will be evaluated during the clinical trial in comparison with a reference medical device already on the market. The main goals are to achieve (i) better sensitivity of bladder cancers' cystocopic diagnosis and shorter medical examination durations thanks to the simultaneous visualization of the bladder inner wall with white and blue lights and (ii) better patients' follow up thanks to the high resolved panoramic images.

Registry
clinicaltrials.gov
Start Date
July 4, 2016
End Date
October 6, 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Institut de Cancérologie de Lorraine
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \>18 years
  • Patient with suspicion of a bladder cancer or a suspected recurrence of a bladder cancer
  • Cytological and bacteriological examination of urine culture negative
  • Patient must be affiliated to a social security system
  • Ability to provide written informed consent patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study

Exclusion Criteria

  • Age \< 18 years
  • Bladder infection in progress and untreated
  • Hemorrhage
  • Urethral stenosis
  • Contraindication for a cystoscopy examination
  • Contraindication to administration of Hexvix (porphyria, hypersensitivity to hexylaminolévulinate or excipient of Hexvix (disodium phosphate dihydrate, potassium dihydrogen phosphate)
  • Pregnant or breast feeding females
  • Patients deprived of liberty or under supervision

Outcomes

Primary Outcomes

Ergonomic comparaison of the two devices

Time Frame: 1 day

Ergonomic of the two devices will be evaluated and compared by using the scale NASA TLX (Hart SG, et al., 1998).

Secondary Outcomes

  • Comparison of performing time(1 day)
  • Quality assessment of image(1 day)
  • Quality assessment of device evaluation(1 day)
  • Evaluation of recording capacity of the video sequences to perform real-time image mosaics(1 day)

Study Sites (1)

Loading locations...

Similar Trials